Prescription Drug News and Research

RSS
Drug assistance programs help the medicine go down

Drug assistance programs help the medicine go down

Study shows generics now own 63% of Medicare Part D market

Study shows generics now own 63% of Medicare Part D market

Coalition calls for end of redesigned Medicaid program in West Virginia

Coalition calls for end of redesigned Medicaid program in West Virginia

Pennsylvania Senate Republicans unveil health care plans

Pennsylvania Senate Republicans unveil health care plans

CMS announces $15 million funding increase for Medicare counseling programs

CMS announces $15 million funding increase for Medicare counseling programs

Panel discusses expanding health coverage to uninsured via 'early Medicare' program

Panel discusses expanding health coverage to uninsured via 'early Medicare' program

Calls for tougher rules on complementary medicines in Australia

Calls for tougher rules on complementary medicines in Australia

Nearly 75% of Medicare drug plan beneficiaries will pay 16% more for coverage this year

Nearly 75% of Medicare drug plan beneficiaries will pay 16% more for coverage this year

Louisiana's Charity Hospitals need $35 million to continue services at current levels

Louisiana's Charity Hospitals need $35 million to continue services at current levels

Survey shows Americans regard reducing the cost of prescription drugs as highest health care priority

Survey shows Americans regard reducing the cost of prescription drugs as highest health care priority

Walgreens to pay $35 million to settle Medicaid prescription drug fraud allegations

Walgreens to pay $35 million to settle Medicaid prescription drug fraud allegations

Less than 1 in 5 patients receive treatment to prevent venous thrombosis after surgery

Less than 1 in 5 patients receive treatment to prevent venous thrombosis after surgery

CMS launches campaign to enroll more low-income Medicare beneficiaries in prescription drug assistance program

CMS launches campaign to enroll more low-income Medicare beneficiaries in prescription drug assistance program

Connecticut Attorney General files lawsuit against McKesson over alleged inflation of prescription drug prices

Connecticut Attorney General files lawsuit against McKesson over alleged inflation of prescription drug prices

Maine Democratic Rep. Allen proposes mix of public, private health plans to achieve universal coverage

Maine Democratic Rep. Allen proposes mix of public, private health plans to achieve universal coverage

Maine Democratic Rep. Allen proposes mix of public, private health plans to achieve universal coverage

Maine Democratic Rep. Allen proposes mix of public, private health plans to achieve universal coverage

Brand-name prescription drug companies reached 14 deals with generic manufacturers to delay sale of generics in FY 2007

Brand-name prescription drug companies reached 14 deals with generic manufacturers to delay sale of generics in FY 2007

U.S. Government 'must take lead' in health care IT, former Rep. Johnson writes

U.S. Government 'must take lead' in health care IT, former Rep. Johnson writes

FDA proposes major revisions to the physician labeling for prescription drugs

FDA proposes major revisions to the physician labeling for prescription drugs

FDA will monitor medical records of Medicare beneficiaries to identify potential prescription drug, medical device safety problems

FDA will monitor medical records of Medicare beneficiaries to identify potential prescription drug, medical device safety problems

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.